Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics

Published:2017-11 Issue:2 Volume:532 Page:660-668
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Bruniaux J.,Djemaa S. Ben,Hervé-Aubert K.,Marchais H.,Chourpa I.,David S.

Funder

Institut National du Cancer (INCa)

Fondation ARC

Ligue Nationale Contre le Cancer (LNCC)

Région Centre-Val de Loire

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis;Akinc;J. Gene Med.,2005

2. Covalent conjugation of cysteine-engineered scFv to PEGylated magnetic nanoprobes for immunotargeting of breast cancer cells;Alric;RSC Adv .,2016

3. Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system;Cheong;Int. J. Pharm.,2009

4. Modelling the response surface to predict the hydrodynamic diameters of theranostic magnetic siRNA nanovectors;David;Int. J. Pharm.,2015

5. Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN);David;Int. J. Pharm.,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in magnetic nanocarriers for tumor treatment;Biomedicine & Pharmacotherapy;2023-03

2. WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model;International Journal of Pharmaceutics;2023-02

3. IONPs-Based Treatment Methods;Nanomedicine and Nanotoxicology;2023

4. siRNA and targeted delivery systems in breast cancer therapy;Clinical and Translational Oncology;2022-12-23

5. In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model;International Journal of Pharmaceutics: X;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3